Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001489966-26-000004
Filing Date
2026-05-04
Accepted
2026-05-04 16:10:00
Documents
1
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4352
  Complete submission text file 0001489966-26-000004.txt   5928
Mailing Address C/O LAVA THERAPEUTICS BV YALEAAN 62 3584 CM ULTRECHT Netherlands
Business Address
Morris Charles Q (Reporting) CIK: 0001489966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 26937655

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)